Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Eating phenylthiocarbamide made all the rats' hair go gray, but some returned to their original color after stopping.

Microparticles help caffeic acid stay longer in hair follicles for better treatment of folliculitis.

Certain compounds from Stephania cepharantha help hair cell growth.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

The treatment was not recommended due to limited effectiveness and significant side effects.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Blocking certain brain processes reduces mating behavior in female rats.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Low-dose rapamycin microdepots can help regrow hair by activating certain cell processes.

CTP-543 is generally safe for treating alopecia areata.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Targeted cancer therapies often cause serious skin problems that need careful management.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Finasteride may help treat childhood brain tumors by activating certain genes.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.